Global Operations Asset Leader; GOAL

At Roche you can show up as yourself, embraced for the unique qualities you bring

Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.

At Roche/Genentech Pharma Product Development Global Clinical Operations (PDG), we are determined to transform drug development and realize our Pharma Ambition to deliver 20 transformative medicines addressing diseases with the highest societal burden by 2029. We are looking for a Global Operations Asset Leader to lead and drive the operational delivery of one (or more) of our assets. This people leadership position holds significant accountability for clinical operations strategy and execution as well as enterprise collaboration.

PD’s mission is to improve patients’ lives around the world through unique medicines that have a meaningful impact. Cross functionally we conduct global clinical trials, analyze results, monitor safety, and work with regulatory authorities to provide truly differentiated medicines to patients. Our primary disease focus areas are Oncology, Hematology, Neurology, Immunology, Ophthalmology, Cardiovascular, Renal, and Metabolism (CVRM). We attract, develop, and retain the most talented people in the industry, within PDG’s Clinical Operations Country Footprint.

The Global Operations Asset Leader (GOAL) in PDG at Roche/Genentech is accountable and responsible for the clinical operations delivery of one or more assets in line with budget, timelines and quality expectations, including timely and accurate data entry in our systems at both a study and asset level. One asset comprises multiple clinical studies.

The GOAL is accountable for delivering an Asset’s portfolio of clinical studies within a TA/DA through architecting and translating the overall operational strategy and business needs, in partnership with the appropriate Therapeutic Area and Disease Area Leaders, Country leaders and other key PDG and enterprise senior stakeholders. The Operations Asset Leader will represent the PDG perspective at the Global Development and Lifecycle Teams and will develop and continuously adapt the Asset strategy and tactics to ensure the overall clinical operations delivery meets or exceeds delivery expectations.

Build, strengthen, and influence a broad multi leveled cross-functional network through collaboration and informed decision-making across early and late-stage development, while providing strategic operational leadership. The stakeholders include, but are not limited to:

• PDG:
  Translate Late Stage Portfolio Committee (LSPC) One Portfolio priorities into PDG asset delivery while balancing the overall business need, and making informed trade-offs at the asset and study level.
• Serve as the decision maker for the operational asset decisions in collaboration with the TA leader, Study leaders and Country leaders to optimize overall portfolio delivery.
• Partner closely and leverage PDG’s Analytics and Portfolio Optimization (APO) and Clinical Operations Excellence (COE) expertise to accelerate speed, enhance efficiency and quality, manage budget, improve PTS, ensure a patient- and investigator/site-centric approach including health equity research commitments at the asset level. Drive innovation in clinical operations by thinking of and contributing to the implementation of new approaches in partnership with COE, APO and HBS in order to deliver outcomes that meet and exceed industry best practices.
• Accountable for accuracy and timeliness of data in our systems, regardless of who is accountable or responsible for entering.
• Partner effectively with PDG Human Biosamples team to support adherence to bioethics, quality and compliance needs of human biosamples in sample collection, storage and destruction.

Collaborate (directly…